Jinxin Fertility Group Limited

DB:3NX Stock Report

Market Cap: €950.6m

Jinxin Fertility Group Past Earnings Performance

Past criteria checks 4/6

Jinxin Fertility Group's earnings have been declining at an average annual rate of -6.3%, while the Healthcare industry saw earnings growing at 7.2% annually. Revenues have been growing at an average rate of 16.5% per year. Jinxin Fertility Group's return on equity is 3.1%, and it has net margins of 10.7%.

Key information

-6.3%

Earnings growth rate

-11.6%

EPS growth rate

Healthcare Industry Growth15.7%
Revenue growth rate16.5%
Return on equity3.1%
Net Margin10.7%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Jinxin Fertility Group makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:3NX Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 242,89931170022
31 Mar 242,84432868722
31 Dec 232,78934567322
30 Sep 232,67525065923
30 Jun 232,56015564423
31 Mar 232,46213862720
31 Dec 222,36412161017
30 Sep 222,24124853514
30 Jun 222,11837446010
31 Mar 221,97835742511
31 Dec 211,83934038911
30 Sep 211,75631638211
30 Jun 211,67429137612
31 Mar 211,55027134612
31 Dec 201,42625231711
30 Sep 201,44830430112
30 Jun 201,46935628612
31 Mar 201,55938328013
31 Dec 191,64841027413
30 Sep 191,47533922013
30 Jun 191,30126916612
31 Mar 191,11221813512
31 Dec 1892216710312
31 Dec 17663996010
31 Dec 1634688260

Quality Earnings: 3NX has high quality earnings.

Growing Profit Margin: 3NX's current net profit margins (10.7%) are higher than last year (6%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 3NX's earnings have declined by 6.3% per year over the past 5 years.

Accelerating Growth: 3NX's earnings growth over the past year (101.1%) exceeds its 5-year average (-6.3% per year).

Earnings vs Industry: 3NX earnings growth over the past year (101.1%) exceeded the Healthcare industry 40.5%.


Return on Equity

High ROE: 3NX's Return on Equity (3.1%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 09:32
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Jinxin Fertility Group Limited is covered by 30 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Sharon ShiBOCI Research Ltd.
Ethan CuiBofA Global Research
Qianyi LiChina International Capital Corporation Limited